Schadendorf, D.; Dummer, R.; Hauschild, A.; Santinami, M.; Atkinson, V.; Mandala, M.; Chiarion-Sileni, V.; Larkin, J.; Nyakas, M.; Dutriaux, C.; Haydon, A.; Mortier, L.; Robert, C.; Schachter, J.; Ortmann, C.-E.; de Jong, E.; Gasal, E.; Kefford, R.; Kirkwood, J. M.; Long, G. V. Association Between Baseline Disease Characteristics and Relapse-Free Survival in Patients With BRAF V600–Mutant Resected Stage III Melanoma Treated With Adjuvant Dabrafenib + Trametinib or Placebo. J of Skin 2019, 3, S53.